The effects of milrinone on hemodynamics in an experimental septic shock model

Pediatric Critical Care Medicine

Volumn 6, Issue 2, 2005, Pages 195-199

  Liet, Jean Michel ^a   Jacqueline, Cédric ^b   Orsonneau, Jean Luc ^a   Gras LeGuen, Christèle ^a   Potel, Gilles ^b   Rozé, Jean Christophe ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Hemodynamics; Milrinone; Phosphodiesterase inhibitor; Sepsis; Shock

Indexed keywords

CREATINE; GLUCOSE; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL CATHETERIZATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; EXPERIMENTAL MODEL; FEMALE; FEMORAL ARTERY; HEALTH CARE FACILITY; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; JUGULAR VEIN; LACTIC ACIDEMIA; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RABBIT; RANDOMIZATION; RECORDING; SEDATION; SEPTIC SHOCK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THERMODILUTION; TISSUE PERFUSION;

ANIMALS; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMIC PROCESSES; HYPOTENSION; MILRINONE; OXYGEN CONSUMPTION; PHOSPHODIESTERASE INHIBITORS; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; RABBITS; RANDOM ALLOCATION; SHOCK, SEPTIC;

EID: 19444378699     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000155636.53455.96     Document Type: Article

References (33)

1. Werner HA, Herbertson MJ, Walley KR: Amrinone increases ventricular contractility and diastolic compliance in endotoxemia. Am J Respir Crit Care Med 1995; 152:496-503
2. Chang AC, Atz AM, Wernovsky G, et al: Milrinone: Systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23:1907-1914
3. Hoffman TM, Wernovsky G, Atz AM, et al: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002
4. Barton P, Garcia J, Kouatli A, et al: Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996; 109:1302-1312
5. Irazuzta JE, Pretzlaff RK, Rowin ME: Amrinone in pediatric refractory septic shock: An open-label pharmacodynamic study. Pediatr Crit Care Med 2001; 2:24-28
6. Rich N, West N, McMaster P, et al: Milrinone in meningococcal sepsis. Pediatr Crit Care Med 2003; 4:394-395
7. Ringe HI, Varnholt W, Gaedicke G: Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediatr Crit Care Med 2003; 4:471-475
8. Carcillo JA, Fields AI, American College of Critical Care Medicine Task Force Committee Members: Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. 2002; 30:1365-1378
9. Tibby SM, Hatherill M, Marsh MJ, et al: Clinical validation of cardiac output measurements using femoral artery thermodilution with direct Fick in ventilated children and infants. Intensive Care Med 1997; 23: 987-991
10. Pauli C, Fakler U, Genz T, et al: Cardiac output determination in children: Equivalence of the transpulmonary thermodilution method to the direct Fick principle. Intensive Care Med 2002; 28:947-952
11. Sakka SG, Ruhl CC, Pfeiffer UJ, et al: Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med 2000; 26: 180-187
12. Schiffmann H, Erdlenbruch B, Singer D, et al: Assessment of cardiac output, intravascular volume status, and extravascular lung water by transpulmonary indicator dilution in critically ill neonates and infants. J Cardiothorac Vasc Anesth 2002; 16:592-597
13. Lindsay CA, Barton P, Lawless S, et al: Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 1998; 132:329-334.
14. Marbach EP, Weil MH: Rapid enzymatic measurement of blood lactate and pyruvate. Clin Chem 1967; 13:314-325
15. Foster-Swanson A, Swartzentruber M, Roberts P, et al: Reference interval studies of the rate-blanked creatinine/Jaffe method on BM/Hitachi systems in six US laboratories. Clin Chem 1994; 40:1057
16. Kienbaum P, Heuter T, Michel MC, et al: Racemic ketamine decreases muscle sympathetic activity but maintains the neural response to hypotensive challenges in humans. Anesthesiology 2000; 92:94-101
17. White PF: Comparative evaluation of intravenous agents for rapid sequence induction: thiopental, ketamine, and midazolam. Anesthesiology 1982; 57:279-284
18. Duke TD, Butt W, South M: Predictors of mortality and multiple organ failure in children with sepsis. Intensive Care Med 1997; 23:684-692
19. Hatherill M, Waggie Z, Purves L, et al: Mortality and the nature of metabolic acidosis in children with shock. Intensive Care Med 2003; 29:286-291
20. Reinhart K, Rudolph T, Bredle DL, et al: Comparison of central-venous to mixed-venous oxygen saturation during changes in oxygen supply/demand. Chest 1989; 95: 1216-1221
21. Rivers E, Nguyen B, Havstad S, et al, Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
22. Lin Y, Leach WJ, Ammons WS: Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit Gram-negative sepsis. Antimicrob Agents Chemother 1996; 40:65-69
23. Nuwayhid B: Hemodynamic changes during pregnancy in the rabbit. Am J Obstet Gynecol 1979; 135:590-596
24. Ricard-Hibon A, Losser MR, Kong R, et al: Systemic pressure-flow reactivity to norepinephrine in rabbits: Impact of endotoxin and fluid loading. Intensive Care Med 1998; 24: 959-966
25. Giroir BP, Beutler B: Effect of amrinone on tumor necrosis factor production in endotoxic shock. Circ Shock 1992; 36:200-207
26. Hayashida N, Tomoeda H, Oda T, et al: Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. Ann Thorac Surg 1999; 68:1661-1667
27. Heinz G, Geppert A, Delle Karth G, et al: IV milrinone for cardiac output increase and maintenance: Comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure. Intensive Care Med 1999; 25:620-624
28. Kern H, Schroder T, Kaulfuss M, et al: Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 2001; 29:1519-1525
29. Lauterbach R, Pawlik D, Kowalczyk D, et al: Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 1999; 27:807-814
30. Haque K, Mohan P: Pentoxifylline for neonatal sepsis. Cochrane Database Syst Rev 2003; 4:CD004205
31. Lindgren S, Almqvist P, Arvidsson D, et al: Lack of beneficial effects of milrinone in severe septic shock. Circ Shock 1990; 31: 365-375
32. Tibby SM, Hatherill M, Marsh MJ, et al: Clinicians' abilities to estimate cardiac index in ventilated children and infants. Arch Dis Child 1997; 77:516-518
33. Buwalda M, Ince C: Opening the microcirculation: Can vasodilators be useful in sepsis? Intensive Care Med 2002; 28:1208-1217